LifeStance Expands Clinician Base, Raises EBITDA Guidance for 2025

LifeStance Health Group has raised its adjusted EBITDA guidance and targets double-digit margins for FY2025. The company expanded AI and clinician initiatives, growing its clinician base by over 170 clinicians. CEO David Patrick Bourdon highlighted strong Q2 results, stating the company met or exceeded each of its guided metrics.

LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, has reported robust financial results for the second quarter ended June 30, 2025, and raised its adjusted EBITDA guidance for the full year. The company announced that its adjusted EBITDA for the second quarter increased by 19% to $34.0 million, driven by double-digit organic revenue growth and improved operating leverage [1].

CEO David Patrick Bourdon highlighted the company's strong performance, stating, "We grew our clinician base by over 170 clinicians while at the same time improving productivity. We delivered double-digit organic revenue growth along with 10% Adjusted EBITDA margins, and are raising our full year guidance midpoint for Adjusted EBITDA by $5 million" [1].

The company's revenue grew 11% to $345.3 million, with visit volumes increasing by 12% to 2.2 million. The net loss was $3.8 million, down from $23.3 million in the prior year. LifeStance also reported a net cash provided by operations of $64.4 million in the second quarter, and a positive free cash flow of $56.6 million [1].

For the full year 2025, LifeStance has raised its expectations for revenue to $1.40 billion to $1.44 billion, Center Margin to $441 million to $465 million, and Adjusted EBITDA to $140 million to $150 million. The company expects total revenue of $345 million to $365 million for the third quarter of 2025, Center Margin of $105 million to $119 million, and Adjusted EBITDA of $33 million to $39 million [1].

LifeStance has been expanding its AI and clinician initiatives, which have contributed to the growth in its clinician base. The company's mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable, and personalized mental healthcare [1].

References:
[1] https://finance.yahoo.com/news/lifestance-reports-second-quarter-2025-100000172.html